Most impactful areas to clinical real-world evidence as of 2018

Percentage of executives that said select areas would be most impactful to current and future real-world evidence (RWE) as of 2018*

by Matej Mikulic, last edited Feb 26, 2019
Most impactful areas to clinical real-world evidence as of 2018 This statistic depicts the percentage of executives that selected current and projected areas of most impact to real-world evidence (RWE) in clinical trials, as of 2018. According to the source, 60 percent of executives said that a better understanding of subpopulations and heterogeneity of treatment effects would be most impactful to current real-world evidence.
Show more

Percentage of executives that said select areas would be most impactful to current and future real-world evidence (RWE) as of 2018*

Loading statistic...
Expand statistic
CurrentFuture
Better understanding subpopulations and heterogeneity of treatment effects60%40%
Understanding burdern of disease60%5%
Monitoring patient safety (i.e., pharmacovigilance)50%30%
Comparative effectiveness research35%20%
Supporting regulatory submission and or label expansion20%45%
Accelerating the execution of clinical trials using RWD as a control arm for clinical trials15%35%
Optimizing the design of clinical trials10%50%
Identifying new drug targets/areas of unmet needs10%20%
Design of value-based contracting schemes5%40%
Biomarker hypothesis generation/validation10%10%
Supporting patient engagement programs0%5%
Measuring sales performance, targeting, and marketing metrics0%0%
Informing business development and portfolio strategy (therapeutic area assessment)0%0%
Informing pricing strategies0%0%
CurrentFuture
Better understanding subpopulations and heterogeneity of treatment effects60%40%
Understanding burdern of disease60%5%
Monitoring patient safety (i.e., pharmacovigilance)50%30%
Comparative effectiveness research35%20%
Supporting regulatory submission and or label expansion20%45%
Accelerating the execution of clinical trials using RWD as a control arm for clinical trials15%35%
Optimizing the design of clinical trials10%50%
Identifying new drug targets/areas of unmet needs10%20%
Design of value-based contracting schemes5%40%
Biomarker hypothesis generation/validation10%10%
Supporting patient engagement programs0%5%
Measuring sales performance, targeting, and marketing metrics0%0%
Informing business development and portfolio strategy (therapeutic area assessment)0%0%
Informing pricing strategies0%0%
Download Settings Share
Download started
Please be patient - this may take a moment
by Matej Mikulic, last edited Feb 26, 2019
This statistic depicts the percentage of executives that selected current and projected areas of most impact to real-world evidence (RWE) in clinical trials, as of 2018. According to the source, 60 percent of executives said that a better understanding of subpopulations and heterogeneity of treatment effects would be most impactful to current real-world evidence.
Show more
Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "Clinical trials"
  • R&D overview
  • Top R&D companies
  • Clinical studies
  • Participation
  • Costs and market
  • Success rates
  • Approvals, launches, setbacks
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.